Page 1 of 7

Experimental Longevity Drug Survey

Would you like early access to longevity drugs? Answer this survey leaving your email at the end and we will put you on a waiting list! This survey assesses interest and requirements for experimental longevity protocols. About 3 minutes · optional extras after.
Recent reforms in the Bahamas and in Montana (United States) let people try experimental longevity drugs years ahead of full approval and get data about their individual response (MIT Technology Review). Candidate drugs must meet safety requirements, such as completion of Phase 1 trials and approval from an Experimental Treatment Review Board.

Consent

Run by Vitality Now (VitaDAO) with Infinita, LARTA and Wildcreek. Share only what you're comfortable with; results are published only anonymized and aggregated. Email is optional. Read the full privacy notice.